Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms

Terra L. Lasho; Rangit Vallapureddy; Christy M. Finke; Abhishek Mangaonkar; Naseema Gangat; Rhett Ketterling; Ayalew Tefferi; Mrinal M. Patnaik

doi:10.1038/s41408-018-0057-8

Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms

Terra L. Lasho
, Rangit Vallapureddy
, Christy M. Finke
, Abhishek Mangaonkar
, Naseema Gangat
, Rhett Ketterling
, Ayalew Tefferi
, Mrinal M. Patnaik

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Article number	32
Journal	Blood cancer journal
Volume	8
Issue number	3
DOIs	https://doi.org/10.1038/s41408-018-0057-8
State	Published - Mar 1 2018

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1038/s41408-018-0057-8

Cite this

@article{f52208a421ae40f68b8c0d75b3b133dd,

title = "Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms",

author = "Lasho, \{Terra L.\} and Rangit Vallapureddy and Finke, \{Christy M.\} and Abhishek Mangaonkar and Naseema Gangat and Rhett Ketterling and Ayalew Tefferi and Patnaik, \{Mrinal M.\}",

note = "Funding Information: Current publication is supported in part by grants from the “The Gerstner Family Career Development Award” and the Mayo Clinic Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA”. This publication was supported by CTSA Grant Number KL2 TR000136 from the National Center for Advancing Translational Science (NCATS). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.",

year = "2018",

month = mar,

day = "1",

doi = "10.1038/s41408-018-0057-8",

language = "English (US)",

volume = "8",

journal = "Blood cancer journal",

issn = "2044-5385",

publisher = "Springer Nature",

number = "3",

}

TY - JOUR

T1 - Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms

AU - Lasho, Terra L.

AU - Vallapureddy, Rangit

AU - Finke, Christy M.

AU - Mangaonkar, Abhishek

AU - Gangat, Naseema

AU - Ketterling, Rhett

AU - Tefferi, Ayalew

AU - Patnaik, Mrinal M.

N1 - Funding Information: Current publication is supported in part by grants from the “The Gerstner Family Career Development Award” and the Mayo Clinic Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA”. This publication was supported by CTSA Grant Number KL2 TR000136 from the National Center for Advancing Translational Science (NCATS). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.

PY - 2018/3/1

Y1 - 2018/3/1

UR - https://www.scopus.com/pages/publications/85044195484

UR - https://www.scopus.com/pages/publications/85044195484#tab=citedBy

U2 - 10.1038/s41408-018-0057-8

DO - 10.1038/s41408-018-0057-8

M3 - Letter

C2 - 29531217

AN - SCOPUS:85044195484

SN - 2044-5385

VL - 8

JO - Blood cancer journal

JF - Blood cancer journal

IS - 3

M1 - 32

ER -

Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this